VRCA 8-K 2026-08-06

Verrica Pharmaceuticals Inc. (VRCA) 8-K dated 2026-08-06 — accession 0001193125-26-338273. This URL is the filing, not the VRCA hub.

Verrica Pharmaceuticals Inc. (VRCA) is a biotechnology company listed on US.

Verrica Pharmaceuticals Inc. filed a 8-K on 2026-08-06. Accession 0001193125-26-338273.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VRCA revenue for 2025-12-31 was $35.6M. Net income was -$17.9M. Revenue was up 594.3% from 2023-12-31 to 2025-12-31. VRCA currently screens at market cap $79.7M.

Not investment advice. The VRCA SEC hub lists recent forms. The stock page is the research view.